Arnold van de Laar

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 356 citations

Medicine, Clinical Sciences, Surgery +12

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 179 citations

Medicine, Surgery, Gastroenterology +10

Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects

Barbara A. de Weijer, Elsmarieke van de Giessen, Thérèse A. van Amelsvoort et al. · EJNMMI Research · 2011 · 177 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

Relative Outcome Measures for Bariatric Surgery. Evidence Against Excess Weight Loss and Excess Body Mass Index Loss from a Series of Laparoscopic Roux-en-Y Gastric Bypass Patients

Arnold van de Laar, Laura de Caluwé, Bruno Dillemans · Obesity Surgery · 2010 · 117 citations

Medicine, Nutrition, Surgery +16

Sensitivity and Specificity of 50% Excess Weight Loss (50%EWL) and Twelve Other Bariatric Criteria for Weight Loss Success

Arnold van de Laar, A. S. van Rijswijk, Hala Kakar et al. · Obesity Surgery · 2018 · 107 citations

Agriculture, Nutrition, Nutritional Sciences +11